Clinical Trial Update: Cochlear-Vestibular Ganglion (CVG) in Newly Diagnosed Type 2 Diabetes Patients [NA]

View source ↗

Summary

A clinical trial investigating Cochlear-Vestibular Ganglion (CVG) in newly diagnosed Type 2 diabetes mellitus patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: NYU Langone Health | Conditions: Diabetes Mellitus Type 2 in Obese | NA | Status: WITHDRAWN